Raymond James Financial Inc. Acquires New Position in Editas Medicine, Inc. (NASDAQ:EDIT)
Raymond James Financial Inc. bought a new position in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 238,967 shares of the company’s stock, valued at approximately $303,000. Several other hedge funds and other institutional investors have […]
Raymond James Financial Inc. bought a new position in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 238,967 shares of the company’s stock, valued at approximately $303,000. Several other hedge funds and other institutional investors have […]
